https://kalkinemedia.com/au/news/featured-news/chimeric-therapeutics-asxchm-launches-phase-1b-clinical-trial-in-glioblastoma
Chimeric Therapeutics (ASX:CHM) launches Phase 1B clinical trial in glioblastoma